Physician profile

Cameron Fuller

Pediatric Dentistry · Redlands, CA

NPI 1710137690

$282.77

in general payments reported to CMS, 2019-2025

3 companies · $56.50 in 2025

The $56.50 reported for 2025 was more than what a typical Pediatric Dentistry provider received nationally (typical 2025 total: $42.86).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$56.50

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Voco America INC. $162.32 2020
Centrix INC $63.95 2019
Gc America INC. $56.50 2025 G-Aenial, G-Aenial, G-Premio Bond

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Cameron Fuller

$282.77

in general payments reported 2019-2025

Years
2019-2025
Top company
Voco America INC.
Context
The $56.50 reported for 2025 was more than what a typical Pediatric Dentistry provider received nationally (typical 2025 total: $42.86).

https://glasscript.com/doctor/1265614/cameron-fuller

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.